Suchergebnisse - (Person:"Kim, Jin Yong")

PubPharm (3)

1

A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Kim, Y. | Jeon, S. | Kim, J. | +31

2

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

enthalten in: The New England journal of medicine | 2022

von Hammond, J. | Leister-Tebbe, H. | Gardner, A. | +110

CommentIn: Nature. 2022 Apr;604(7906):412-413. - PMID 35379975

3

Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein : Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection

enthalten in: Clinical therapeutics | 2021

von Kim, J. | Jang, Y. | Hong, J. | +16

1
[1]